SCHEMBL8764979

SCHEMBL8764979

CCCCc1ncccc1[O]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.42
TDP1 Q9NUW8 2/20 0.42
KAT2B Q92831 1/20 0.38
NPC1 O15118 2/20 0.37
CASP3 P42574 2/20 0.37
RAB9A P51151 2/20 0.37
SENP8 Q96LD8 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
SENP6 Q9GZR1 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP19A1 P11511 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23020157 0.81 L3MBTL1 (0.42) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL8582607 0.78 L3MBTL1 (0.43) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL510210 0.78 L3MBTL1 (0.43) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL6293250 0.78 L3MBTL1 (0.43) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL25629718 0.78 L3MBTL1 (0.40) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL13073704 0.77 GRM5 (0.43) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL19865639 0.77 L3MBTL1 (0.42) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL11373743 0.77 L3MBTL1 (0.42) L3MBTL1TDP1KAT2BNPC1CASP3
SCHEMBL510211 0.77 CYP2C9 (0.43) L3MBTL1TDP1KAT2BPDE4APDE4B
SCHEMBL24440199 0.77 L3MBTL1 (0.42) L3MBTL1TDP1KAT2BNPC1CASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101522674-B Novel compounds, pharmaceutically acceptable salts as vanilloid receptor antagonist and pharmaceutical composition comprising the compounds AMOREPACIFIC CORP 2013-08-21 CN disclosed
CN-101522674-A Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist AMOREPACIFIC CORP (KR) 2009-09-02 CN disclosed
EP-0778267-A1 SULFONAMIDE DERIVATIVES AND INSECTICIDE, MITICIDE AND NEMATICIDE CONTAINING THE SAME OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1997-06-11 EP disclosed